Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Learn ways to earn money quickly without scams through reliable and safe options. Maximize your earnings with confidence.
24,432 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Hyperliquid's HYPE token surged after a margin upgrade, lifting oil perpetuals to notable trading levels. The move si...
Major cryptocurrencies hold support as regulatory and macro headlines shape momentum. The crypto price prediction tod...
Lucid Group shares fell about 6% as investors grilled the company after a mixed Investor Day, with widening losses an...
Wedbush boosts its Micron price target to $500, arguing demand remains healthy after the Chinese New Year. The upgrad...
Biotech stocks rally as late-stage trial data and regulatory milestones boost investor confidence. Analysts say the b...
U.S. stock futures dip as oil prices rise amid renewed Iran tensions. Traders brace for energy-driven volatility and ...
Dell Technologies rode a wave of AI server demand to a $33.4 billion quarterly revenue, beating expectations and lift...
As the S&P 500 retreats, two growth-focused ETFs show resilience. This report breaks down why FELG and QQQ are defyin...
A growth stock that surged to lofty heights last year has cooled in 2026, but big buyers keep stepping in as AI capac...
Ethereum surged about 8% over the past week, trading around $2,200 as traders weigh the next leg higher. On-chain sig...
The SEC and CFTC jointly designate XRP as a digital commodity alongside Bitcoin and Ethereum, removing its security l...